Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 150

    1.

    Nationwide population-based study on 30-day mortality after radical prostatectomy in Sweden.

    Carlsson S, Adolfsson J, Bratt O, Johansson JE, Ahlstrand C, Holmberg E, Stattin P, Hugosson J.

    Scand J Urol Nephrol. 2009;43(5):350-6.PMID: 19921978 [PubMed - in process]Related articles

    2.

    PCBaSe Sweden: a register-based resource for prostate cancer research.

    Hagel E, Garmo H, Bill-Axelson A, Bratt O, Johansson JE, Adolfsson J, Lambe M, Stattin P.

    Scand J Urol Nephrol. 2009;43(5):342-9.PMID: 19921977 [PubMed - in process]Related articles

    3.

    Detection of polyunsaturated omega-6 fatty acid in human malignant prostate tissue by 1D and 2D high-resolution magic angle spinning NMR spectroscopy.

    Stenman K, Hauksson JB, Gröbner G, Stattin P, Bergh A, Riklund K.

    MAGMA. 2009 Nov 17. [Epub ahead of print]PMID: 19921294 [PubMed - as supplied by publisher]Related articles

    4.

    Long-term temporal trends in cardiovascular and metabolic risk factors.

    Borena W, Stocks T, Strohmaier S, Strasak A, Manjer J, Johansen D, Jonsson H, Rapp K, Concin H, Hallmans G, Stattin P, Ulmer H.

    Wien Klin Wochenschr. 2009 Oct;121(19-20):623-630.PMID: 19921129 [PubMed - as supplied by publisher]Related articles

    5.

    Suicide Risk in Men with Prostate-Specific Antigen-Detected Early Prostate Cancer: A Nationwide Population-Based Cohort Study from PCBaSe Sweden.

    Bill-Axelson A, Garmo H, Lambe M, Bratt O, Adolfsson J, Nyberg U, Steineck G, Stattin P.

    Eur Urol. 2009 Nov 10. [Epub ahead of print]PMID: 19914773 [PubMed - as supplied by publisher]Related articles

    6.

    Macrophage inhibitory cytokine 1: a new prognostic marker in prostate cancer.

    Brown DA, Lindmark F, Stattin P, Bälter K, Adami HO, Zheng SL, Xu J, Isaacs WB, Grönberg H, Breit SN, Wiklund FE.

    Clin Cancer Res. 2009 Nov 1;15(21):6658-64. Epub 2009 Oct 20.PMID: 19843661 [PubMed - in process]Related articles

    7.

    Prostate specific antigen for early detection of prostate cancer: longitudinal study.

    Holmström B, Johansson M, Bergh A, Stenman UH, Hallmans G, Stattin P.

    BMJ. 2009 Sep 24;339:b3537. doi: 10.1136/bmj.b3537.PMID: 19778969 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Identification of a new prostate cancer susceptibility locus on chromosome 8q24.

    Yeager M, Chatterjee N, Ciampa J, Jacobs KB, Gonzalez-Bosquet J, Hayes RB, Kraft P, Wacholder S, Orr N, Berndt S, Yu K, Hutchinson A, Wang Z, Amundadottir L, Feigelson HS, Thun MJ, Diver WR, Albanes D, Virtamo J, Weinstein S, Schumacher FR, Cancel-Tassin G, Cussenot O, Valeri A, Andriole GL, Crawford ED, Haiman CA, Henderson B, Kolonel L, Le Marchand L, Siddiq A, Riboli E, Key TJ, Kaaks R, Isaacs W, Isaacs S, Wiley KE, Gronberg H, Wiklund F, Stattin P, Xu J, Zheng SL, Sun J, Vatten LJ, Hveem K, Kumle M, Tucker M, Gerhard DS, Hoover RN, Fraumeni JF Jr, Hunter DJ, Thomas G, Chanock SJ.

    Nat Genet. 2009 Oct;41(10):1055-7. Epub 2009 Sep 20.PMID: 19767755 [PubMed - indexed for MEDLINE]Related articles

    9.

    Quantitative trait loci predicting circulating sex steroid hormones in men from the NCI-Breast and Prostate Cancer Cohort Consortium (BPC3).

    Ahn J, Schumacher FR, Berndt SI, Pfeiffer R, Albanes D, Andriole GL, Ardanaz E, Boeing H, Bueno-de-Mesquita B, Chanock SJ, Clavel-Chapelon F, Diver WR, Feigelson HS, Gaziano JM, Giovannucci E, Haiman CA, Henderson BE, Hoover RN, Kolonel LN, Kraft P, Ma J, Le Marchand L, Overvad K, Palli D, Stattin P, Stampfer M, Stram DO, Thomas G, Thun MJ, Travis RC, Trichopoulos D, Virtamo J, Weinstein SJ, Yeager M, Kaaks R, Hunter DJ, Hayes RB.

    Hum Mol Genet. 2009 Oct 1;18(19):3749-57. Epub 2009 Jul 2.PMID: 19574343 [PubMed - indexed for MEDLINE]Related articles

    10.

    Insulin-like growth factor-II methylation status in lymphocyte DNA and colon cancer risk in the Northern Sweden Health and Disease cohort.

    Kaaks R, Stattin P, Villar S, Poetsch AR, Dossus L, Nieters A, Riboli E, Palmqvist R, Hallmans G, Plass C, Friesen MD.

    Cancer Res. 2009 Jul 1;69(13):5400-5. Epub 2009 Jun 23.PMID: 19549920 [PubMed - indexed for MEDLINE]Related articles

    11.

    PCBaSe Sweden: A register-based resource for prostate cancer research.

    Hagel E, Garmo H, Bill-Axelson A, Bratt O, Johansson JE, Adolfsson J, Lambe M, Stattin P.

    Scand J Urol Nephrol. 2009 Jun 1:1-8. [Epub ahead of print]PMID: 19488932 [PubMed - as supplied by publisher]Related articles

    12.

    Genetic and plasma variation of insulin-like growth factor binding proteins in relation to prostate cancer incidence and survival.

    Johansson M, McKay JD, Rinaldi S, Wiklund F, Adami HO, Grönberg H, Kaaks R, Stattin P.

    Prostate. 2009 Sep 1;69(12):1281-91.PMID: 19455605 [PubMed - indexed for MEDLINE]Related articles

    13.

    Plasma phyto-oestrogens and prostate cancer in the European Prospective Investigation into Cancer and Nutrition.

    Travis RC, Spencer EA, Allen NE, Appleby PN, Roddam AW, Overvad K, Johnsen NF, Olsen A, Kaaks R, Linseisen J, Boeing H, Nöthlings U, Bueno-de-Mesquita HB, Ros MM, Sacerdote C, Palli D, Tumino R, Berrino F, Trichopoulou A, Dilis V, Trichopoulos D, Chirlaque MD, Ardanaz E, Larranaga N, Gonzalez C, Suárez LR, Sánchez MJ, Bingham S, Khaw KT, Hallmans G, Stattin P, Rinaldi S, Slimani N, Jenab M, Riboli E, Key TJ.

    Br J Cancer. 2009 Jun 2;100(11):1817-23. Epub 2009 May 12.PMID: 19436304 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Established prostate cancer susceptibility variants are not associated with disease outcome.

    Wiklund FE, Adami HO, Zheng SL, Stattin P, Isaacs WB, Grönberg H, Xu J.

    Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1659-62.PMID: 19423541 [PubMed - indexed for MEDLINE]Related articles

    15.

    Genetic variation in the SST gene and its receptors in relation to circulating levels of insulin-like growth factor-I, IGFBP3, and prostate cancer risk.

    Johansson M, McKay JD, Wiklund F, Rinaldi S, Hallmans G, Bälter K, Adami HO, Grönberg H, Stattin P, Kaaks R.

    Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1644-50.PMID: 19423539 [PubMed - indexed for MEDLINE]Related articles

    16.

    One-carbon metabolism and prostate cancer risk: prospective investigation of seven circulating B vitamins and metabolites.

    Johansson M, Van Guelpen B, Vollset SE, Hultdin J, Bergh A, Key T, Midttun O, Hallmans G, Ueland PM, Stattin P.

    Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1538-43.PMID: 19423531 [PubMed - indexed for MEDLINE]Related articles

    17.

    Nationwide population-based study on 30-day mortality after radical prostatectomy in Sweden.

    Carlsson S, Adolfsson J, Bratt O, Johansson JE, Ahlstrand C, Holmberg E, Stattin P, Hugosson J.

    Scand J Urol Nephrol. 2009 Apr 24:1-7. [Epub ahead of print]PMID: 19396725 [PubMed - as supplied by publisher]Related articles

    18.

    Cohort Profile: The Metabolic syndrome and Cancer project (Me-Can).

    Stocks T, Borena W, Strohmaier S, Bjørge T, Manjer J, Engeland A, Johansen D, Selmer R, Hallmans G, Rapp K, Concin H, Jonsson H, Ulmer H, Stattin P.

    Int J Epidemiol. 2009 Apr 20. [Epub ahead of print] No abstract available. PMID: 19380371 [PubMed - as supplied by publisher]Related articlesFree article

    19.

    Serum vitamin D and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition (EPIC).

    Travis RC, Crowe FL, Allen NE, Appleby PN, Roddam AW, Tjønneland A, Olsen A, Linseisen J, Kaaks R, Boeing H, Kröger J, Trichopoulou A, Dilis V, Trichopoulos D, Vineis P, Palli D, Tumino R, Sieri S, Bueno-de-Mesquita HB, van Duijnhoven FJ, Chirlaque MD, Barricarte A, Larrañaga N, González CA, Argüelles MV, Sánchez MJ, Stattin P, Hallmans G, Khaw KT, Bingham S, Rinaldi S, Slimani N, Jenab M, Riboli E, Key TJ.

    Am J Epidemiol. 2009 May 15;169(10):1223-32. Epub 2009 Apr 9.PMID: 19359375 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Endogenous steroid hormone levels in early pregnancy and risk of testicular cancer in the offspring: a nested case-referent study.

    Holl K, Lundin E, Surcel HM, Grankvist K, Koskela P, Dillner J, Hallmans G, Wadell G, Olafsdottir GH, Ogmundsdottir HM, Pukkala E, Lehtinen M, Stattin P, Lukanova A.

    Int J Cancer. 2009 Jun 15;124(12):2923-8.PMID: 19330837 [PubMed - indexed for MEDLINE]Related articles

    21.

    A novel prostate cancer susceptibility locus at 19q13.

    Hsu FC, Sun J, Wiklund F, Isaacs SD, Wiley KE, Purcell LD, Gao Z, Stattin P, Zhu Y, Kim ST, Zhang Z, Liu W, Chang BL, Walsh PC, Duggan D, Carpten JD, Isaacs WB, Grönberg H, Xu J, Zheng SL.

    Cancer Res. 2009 Apr 1;69(7):2720-3. Epub 2009 Mar 24.PMID: 19318570 [PubMed - indexed for MEDLINE]Related articles

    22.

    Association of a germ-line copy number variation at 2p24.3 and risk for aggressive prostate cancer.

    Liu W, Sun J, Li G, Zhu Y, Zhang S, Kim ST, Sun J, Wiklund F, Wiley K, Isaacs SD, Stattin P, Xu J, Duggan D, Carpten JD, Isaacs WB, Grönberg H, Zheng SL, Chang BL.

    Cancer Res. 2009 Mar 15;69(6):2176-9. Epub 2009 Mar 3.PMID: 19258504 [PubMed - indexed for MEDLINE]Related articles

    23.

    Maternal smoking during pregnancy and testicular cancer in the sons: a nested case-control study and a meta-analysis.

    Tuomisto J, Holl K, Rantakokko P, Koskela P, Hallmans G, Wadell G, Stattin P, Dillner J, Ogmundsdottir HM, Vartiainen T, Lehtinen M, Pukkala E.

    Eur J Cancer. 2009 Jun;45(9):1640-8. Epub 2009 Feb 21. Review.PMID: 19231156 [PubMed - indexed for MEDLINE]Related articles

    24.

    Genetic variation in the upstream region of ERG and prostate cancer.

    Lindström S, Adami HO, Bälter K, Xu J, Zheng SL, Sun J, Stattin P, Grönberg H, Wiklund F.

    Cancer Causes Control. 2009 Sep;20(7):1173-80. Epub 2009 Feb 10.PMID: 19205910 [PubMed - indexed for MEDLINE]Related articles

    25.

    Low stroma androgen receptor level in normal and tumor prostate tissue is related to poor outcome in prostate cancer patients.

    Wikström P, Marusic J, Stattin P, Bergh A.

    Prostate. 2009 Jun 1;69(8):799-809.PMID: 19189305 [PubMed - indexed for MEDLINE]Related articles

    26.

    Genetic variants and family history predict prostate cancer similar to prostate-specific antigen.

    Zheng SL, Sun J, Wiklund F, Gao Z, Stattin P, Purcell LD, Adami HO, Hsu FC, Zhu Y, Adolfsson J, Johansson JE, Turner AR, Adams TS, Liu W, Duggan D, Carpten JD, Chang BL, Isaacs WB, Xu J, Grönberg H.

    Clin Cancer Res. 2009 Feb 1;15(3):1105-11.PMID: 19188186 [PubMed - indexed for MEDLINE]Related articles

    27.

    Sequence variants at 22q13 are associated with prostate cancer risk.

    Sun J, Zheng SL, Wiklund F, Isaacs SD, Li G, Wiley KE, Kim ST, Zhu Y, Zhang Z, Hsu FC, Turner AR, Stattin P, Liu W, Kim JW, Duggan D, Carpten J, Isaacs W, Grönberg H, Xu J, Chang BL.

    Cancer Res. 2009 Jan 1;69(1):10-5.PMID: 19117981 [PubMed - indexed for MEDLINE]Related articles

    28.

    Association of reported prostate cancer risk alleles with PSA levels among men without a diagnosis of prostate cancer.

    Wiklund F, Zheng SL, Sun J, Adami HO, Lilja H, Hsu FC, Stattin P, Adolfsson J, Cramer SD, Duggan D, Carpten JD, Chang BL, Isaacs WB, Grönberg H, Xu J.

    Prostate. 2009 Mar 1;69(4):419-27.PMID: 19116992 [PubMed - indexed for MEDLINE]Related articles

    29.

    Plasma selenium concentration and prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition (EPIC).

    Allen NE, Appleby PN, Roddam AW, Tjønneland A, Johnsen NF, Overvad K, Boeing H, Weikert S, Kaaks R, Linseisen J, Trichopoulou A, Misirli G, Trichopoulos D, Sacerdote C, Grioni S, Palli D, Tumino R, Bueno-de-Mesquita HB, Kiemeney LA, Barricarte A, Larrañaga N, Sánchez MJ, Agudo A, Tormo MJ, Rodriguez L, Stattin P, Hallmans G, Bingham S, Khaw KT, Slimani N, Rinaldi S, Boffetta P, Riboli E, Key TJ; European Prospective Investigation into Cancer and Nutrition.

    Am J Clin Nutr. 2008 Dec;88(6):1567-75.PMID: 19064517 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    A high cannabinoid CB(1) receptor immunoreactivity is associated with disease severity and outcome in prostate cancer.

    Chung SC, Hammarsten P, Josefsson A, Stattin P, Granfors T, Egevad L, Mancini G, Lutz B, Bergh A, Fowler CJ.

    Eur J Cancer. 2009 Jan;45(1):174-82. Epub 2008 Dec 4.PMID: 19056257 [PubMed - indexed for MEDLINE]Related articles

    31.

    Fatty acid composition of plasma phospholipids and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition.

    Crowe FL, Allen NE, Appleby PN, Overvad K, Aardestrup IV, Johnsen NF, Tjønneland A, Linseisen J, Kaaks R, Boeing H, Kröger J, Trichopoulou A, Zavitsanou A, Trichopoulos D, Sacerdote C, Palli D, Tumino R, Agnoli C, Kiemeney LA, Bueno-de-Mesquita HB, Chirlaque MD, Ardanaz E, Larrañaga N, Quirós JR, Sánchez MJ, González CA, Stattin P, Hallmans G, Bingham S, Khaw KT, Rinaldi S, Slimani N, Jenab M, Riboli E, Key TJ.

    Am J Clin Nutr. 2008 Nov;88(5):1353-63.PMID: 18996872 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    Body size and risk of prostate cancer in the European prospective investigation into cancer and nutrition.

    Pischon T, Boeing H, Weikert S, Allen N, Key T, Johnsen NF, Tjønneland A, Severinsen MT, Overvad K, Rohrmann S, Kaaks R, Trichopoulou A, Zoi G, Trichopoulos D, Pala V, Palli D, Tumino R, Sacerdote C, Bueno-de-Mesquita HB, May A, Manjer J, Wallström P, Stattin P, Hallmans G, Buckland G, Larrañaga N, Chirlaque MD, Martínez C, Redondo Cornejo ML, Ardanaz E, Bingham S, Khaw KT, Rinaldi S, Slimani N, Jenab M, Riboli E.

    Cancer Epidemiol Biomarkers Prev. 2008 Nov;17(11):3252-61.PMID: 18990768 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    Androgens and prostate cancer risk.

    Wirén S, Stattin P.

    Best Pract Res Clin Endocrinol Metab. 2008 Aug;22(4):601-13. Review. Erratum in: Best Pract Res Clin Endocrinol Metab. 2009 Feb;23(1):145. PMID: 18971121 [PubMed - indexed for MEDLINE]Related articles

    34.

    Surveillance and deferred treatment for localized prostate cancer. Population based study in the National Prostate Cancer Register of Sweden.

    Stattin P, Holmberg E, Bratt O, Adolfsson J, Johansson JE, Hugosson J; National Prostate Cancer Register.

    J Urol. 2008 Dec;180(6):2423-9; discussion 2429-30. Epub 2008 Oct 18.PMID: 18930283 [PubMed - indexed for MEDLINE]Related articles

    35.

    Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies.

    Roddam AW, Allen NE, Appleby P, Key TJ, Ferrucci L, Carter HB, Metter EJ, Chen C, Weiss NS, Fitzpatrick A, Hsing AW, Lacey JV Jr, Helzlsouer K, Rinaldi S, Riboli E, Kaaks R, Janssen JA, Wildhagen MF, Schröder FH, Platz EA, Pollak M, Giovannucci E, Schaefer C, Quesenberry CP Jr, Vogelman JH, Severi G, English DR, Giles GG, Stattin P, Hallmans G, Johansson M, Chan JM, Gann P, Oliver SE, Holly JM, Donovan J, Meyer F, Bairati I, Galan P.

    Ann Intern Med. 2008 Oct 7;149(7):461-71, W83-8.PMID: 18838726 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    A prospective analysis of the association between dietary fiber intake and prostate cancer risk in EPIC.

    Suzuki R, Allen NE, Key TJ, Appleby PN, Tjønneland A, Johnsen NF, Jensen MK, Overvad K, Boeing H, Pischon T, Kaaks R, Rohrmann S, Trichopoulou A, Misirli G, Trichopoulos D, Bueno-de-Mesquita HB, van Duijnhoven F, Sacerdote C, Pala V, Palli D, Tumino R, Ardanaz E, Quirós JR, Larrañaga N, Sánchez MJ, Tormo MJ, Jakszyn P, Johansson I, Stattin P, Berglund G, Manjer J, Bingham S, Khaw KT, Egevad L, Ferrari P, Jenab M, Riboli E.

    Int J Cancer. 2009 Jan 1;124(1):245-9.PMID: 18814263 [PubMed - indexed for MEDLINE]Related articles

    37.

    Evidence for two independent prostate cancer risk-associated loci in the HNF1B gene at 17q12.

    Sun J, Zheng SL, Wiklund F, Isaacs SD, Purcell LD, Gao Z, Hsu FC, Kim ST, Liu W, Zhu Y, Stattin P, Adami HO, Wiley KE, Dimitrov L, Sun J, Li T, Turner AR, Adams TS, Adolfsson J, Johansson JE, Lowey J, Trock BJ, Partin AW, Walsh PC, Trent JM, Duggan D, Carpten J, Chang BL, Grönberg H, Isaacs WB, Xu J.

    Nat Genet. 2008 Oct;40(10):1153-5. Epub 2008 Aug 31.PMID: 18758462 [PubMed - indexed for MEDLINE]Related articles

    38.

    A multigenic approach to evaluating prostate cancer risk in a systematic replication study.

    Hsu FC, Lindström S, Sun J, Wiklund F, Chen SH, Adami HO, Turner AR, Liu W, Bälter K, Kim JW, Stattin P, Chang BL, Isaacs WB, Xu J, Grönberg H, Zheng SL.

    Cancer Genet Cytogenet. 2008 Jun;183(2):94-8.PMID: 18503826 [PubMed - indexed for MEDLINE]Related articles

    39.

    Cumulative effect of five genetic variants on prostate cancer risk in multiple study populations.

    Sun J, Chang BL, Isaacs SD, Wiley KE, Wiklund F, Stattin P, Duggan D, Carpten JD, Trock BJ, Partin AW, Walsh PC, Grönberg H, Xu J, Isaacs WB, Zheng SL.

    Prostate. 2008 Sep 1;68(12):1257-62.PMID: 18491292 [PubMed - indexed for MEDLINE]Related articles

    40.

    Alcohol consumption and the risk for prostate cancer in the European Prospective Investigation into Cancer and Nutrition.

    Rohrmann S, Linseisen J, Key TJ, Jensen MK, Overvad K, Johnsen NF, Tjønneland A, Kaaks R, Bergmann MM, Weikert C, Naska A, Trichopoulou A, Trichopoulos D, Pala V, Sacerdote C, Palli D, Tumino R, Bueno-de-Mesquita HB, Vrieling A, González CA, Larrañaga N, Navarro C, Barricarte A, Quiros JR, Martínez-García C, Hallmans G, Stattin P, Manjer J, Wirfält E, Bingham S, Khaw KT, Egevad L, Ferrari P, Jenab M, Riboli E.

    Cancer Epidemiol Biomarkers Prev. 2008 May;17(5):1282-7.PMID: 18483352 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    Dietary fat intake and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition.

    Crowe FL, Key TJ, Appleby PN, Travis RC, Overvad K, Jakobsen MU, Johnsen NF, Tjønneland A, Linseisen J, Rohrmann S, Boeing H, Pischon T, Trichopoulou A, Lagiou P, Trichopoulos D, Sacerdote C, Palli D, Tumino R, Krogh V, Bueno-de-Mesquita HB, Kiemeney LA, Chirlaque MD, Ardanaz E, Sánchez MJ, Larrañaga N, González CA, Quirós JR, Manjer J, Wirfält E, Stattin P, Hallmans G, Khaw KT, Bingham S, Ferrari P, Slimani N, Jenab M, Riboli E.

    Am J Clin Nutr. 2008 May;87(5):1405-13.PMID: 18469265 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Animal foods, protein, calcium and prostate cancer risk: the European Prospective Investigation into Cancer and Nutrition.

    Allen NE, Key TJ, Appleby PN, Travis RC, Roddam AW, Tjønneland A, Johnsen NF, Overvad K, Linseisen J, Rohrmann S, Boeing H, Pischon T, Bueno-de-Mesquita HB, Kiemeney L, Tagliabue G, Palli D, Vineis P, Tumino R, Trichopoulou A, Kassapa C, Trichopoulos D, Ardanaz E, Larrañaga N, Tormo MJ, González CA, Quirós JR, Sánchez MJ, Bingham S, Khaw KT, Manjer J, Berglund G, Stattin P, Hallmans G, Slimani N, Ferrari P, Rinaldi S, Riboli E.

    Br J Cancer. 2008 May 6;98(9):1574-81. Epub 2008 Apr 1.PMID: 18382426 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    The influence of overweight and insulin resistance on breast cancer risk and tumour stage at diagnosis: a prospective study.

    Cust AE, Stocks T, Lukanova A, Lundin E, Hallmans G, Kaaks R, Jonsson H, Stattin P.

    Breast Cancer Res Treat. 2009 Feb;113(3):567-76. Epub 2008 Mar 11.PMID: 18330696 [PubMed - indexed for MEDLINE]Related articles

    44.

    Circulating concentrations of folate and vitamin B12 in relation to prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition study.

    Johansson M, Appleby PN, Allen NE, Travis RC, Roddam AW, Egevad L, Jenab M, Rinaldi S, Kiemeney LA, Bueno-de-Mesquita HB, Vollset SE, Ueland PM, Sánchez MJ, Quirós JR, González CA, Larrañaga N, Chirlaque MD, Ardanaz E, Sieri S, Palli D, Vineis P, Tumino R, Linseisen J, Kaaks R, Boeing H, Pischon T, Psaltopoulou T, Trichopoulou A, Trichopoulos D, Khaw KT, Bingham S, Hallmans G, Riboli E, Stattin P, Key TJ.

    Cancer Epidemiol Biomarkers Prev. 2008 Feb;17(2):279-85.PMID: 18268110 [PubMed - indexed for MEDLINE]Related articlesFree article

    45.

    Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer.

    Gudmundsson J, Sulem P, Rafnar T, Bergthorsson JT, Manolescu A, Gudbjartsson D, Agnarsson BA, Sigurdsson A, Benediktsdottir KR, Blondal T, Jakobsdottir M, Stacey SN, Kostic J, Kristinsson KT, Birgisdottir B, Ghosh S, Magnusdottir DN, Thorlacius S, Thorleifsson G, Zheng SL, Sun J, Chang BL, Elmore JB, Breyer JP, McReynolds KM, Bradley KM, Yaspan BL, Wiklund F, Stattin P, Lindström S, Adami HO, McDonnell SK, Schaid DJ, Cunningham JM, Wang L, Cerhan JR, St Sauver JL, Isaacs SD, Wiley KE, Partin AW, Walsh PC, Polo S, Ruiz-Echarri M, Navarrete S, Fuertes F, Saez B, Godino J, Weijerman PC, Swinkels DW, Aben KK, Witjes JA, Suarez BK, Helfand BT, Frigge ML, Kristjansson K, Ober C, Jonsson E, Einarsson GV, Xu J, Gronberg H, Smith JR, Thibodeau SN, Isaacs WB, Catalona WJ, Mayordomo JI, Kiemeney LA, Barkardottir RB, Gulcher JR, Thorsteinsdottir U, Kong A, Stefansson K.

    Nat Genet. 2008 Mar;40(3):281-3. Epub 2008 Feb 10.PMID: 18264098 [PubMed - indexed for MEDLINE]Related articles

    46.

    The UGT2B17 gene deletion is not associated with prostate cancer risk.

    Olsson M, Lindström S, Häggkvist B, Adami HO, Bälter K, Stattin P, Ask B, Rane A, Ekström L, Grönberg H.

    Prostate. 2008 Apr 1;68(5):571-5.PMID: 18247404 [PubMed - indexed for MEDLINE]Related articles

    47.

    [Healthy life style seems to reduce the risk of cancer. New support for the hypothesis that overweight and high blood glucose increase the cancer risk]

    Stocks T, Lindahl B, Stattin P.

    Lakartidningen. 2007 Dec 19;104(51-52):3867-70. Review. Swedish. No abstract available. PMID: 18232528 [PubMed - indexed for MEDLINE]Related articles

    48.

    Cumulative association of five genetic variants with prostate cancer.

    Zheng SL, Sun J, Wiklund F, Smith S, Stattin P, Li G, Adami HO, Hsu FC, Zhu Y, Bälter K, Kader AK, Turner AR, Liu W, Bleecker ER, Meyers DA, Duggan D, Carpten JD, Chang BL, Isaacs WB, Xu J, Grönberg H.

    N Engl J Med. 2008 Feb 28;358(9):910-9. Epub 2008 Jan 16.PMID: 18199855 [PubMed - indexed for MEDLINE]Related articlesFree article

    49.

    Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP.

    Duggan D, Zheng SL, Knowlton M, Benitez D, Dimitrov L, Wiklund F, Robbins C, Isaacs SD, Cheng Y, Li G, Sun J, Chang BL, Marovich L, Wiley KE, Bälter K, Stattin P, Adami HO, Gielzak M, Yan G, Sauvageot J, Liu W, Kim JW, Bleecker ER, Meyers DA, Trock BJ, Partin AW, Walsh PC, Isaacs WB, Grönberg H, Xu J, Carpten JD.

    J Natl Cancer Inst. 2007 Dec 19;99(24):1836-44. Epub 2007 Dec 11.PMID: 18073375 [PubMed - indexed for MEDLINE]Related articlesFree article

    50.

    Prediction of survival of metastatic prostate cancer based on early serial measurements of prostate specific antigen and alkaline phosphatase.

    Robinson D, Sandblom G, Johansson R, Garmo H, Stattin P, Mommsen S, Varenhorst E; Scandinavian Prostate Cancer Group (SPCG)-5.

    J Urol. 2008 Jan;179(1):117-22; discussion 122-3. Epub 2007 Nov 12.PMID: 17997442 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...